Does a combination pill of antihypertensive drugs improve medication adherence in Japanese?-a randomized controlled trial

Circulation Journal

Volumn 76, Issue 6, 2012, Pages 1415-1422

  Matsumura, Kiyoshi ^a   Arima, Hisatomi ^b   Tominaga, Mitsuhiro ^c   Ohtsubo, Toshio ^a   Sasaguri, Toshiyuki ^d   Fujii, Koji ^e   Fukuhara, Masayo ^d   Uezono, Keiko ^d   Morinaga, Yuki ^a   Ohta, Yuko ^f   Otonari, Takatoshi ^g   Kawasaki, Junya ^h   Kato, Isao ⁱ   Tsuchihashi, Takuya ^f  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF SYDNEY   (Australia)

^c KYUSHU CENTRAL HOSPITAL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e Imazu Sekijuji Hospital   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^g Otonari Clinic   (Japan)

^h Kawasaki Cardiovascular Clinic   (Japan)

ⁱ Kato Clinic   (Japan)

Author keywords

Adherence; Combination pill; Hypertension; Randomized controlled trial

Indexed keywords

ANTIHYPERTENSIVE AGENT; CANDESARTAN; CREATININE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; INDAPAMIDE; LOSARTAN; OLMESARTAN; POTASSIUM; SODIUM; TELMISARTAN; TRICHLORMETHIAZIDE; URIC ACID; VALSARTAN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOCRIT; HUMAN; HYPERTENSION; HYPOTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT COMPLIANCE; PILL; RANDOMIZED CONTROLLED TRIAL; RASH; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DIURETICS; DRUG COMBINATIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; JAPAN; LINEAR MODELS; LOSARTAN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TABLETS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861608927     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1481     Document Type: Article

References (27)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
3. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187.
4. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
5. Ohkubo T, Obara T, Funahashi J, Kikuya M, Asayama K, Metoki H, et al. Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: First report of the Japan home versus office blood pressure measurement evaluation (J-HOME) study. Hypertens Res 2004; 27: 755-763.
6. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818-827.
7. Chobanian AV. The hypertension paradox: More uncontrolled disease despite improved therapy. N Engl J Med 2009; 361: 878-887.
8. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Arch Intern Med 2004; 164: 722-732.
9. Kita T, Yokota N, Ichiki Y, Ayabe T, Etoh T, Tamaki N, et al. Oneyear effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors. Hypertens Res 2010; 33: 320-325.
10. Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 2000; 9(Suppl): 2-6.
11. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: A metaanalysis. Hypertension 2010; 55: 399-407.
12. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: A meta-analysis. Am J Med 2007; 120: 713-719.
13. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1598-1605.
14. Origasa H, Yokoyama M, Matsuzaki M, Saito Y, Matsuzawa Y. Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia. Circ J 2010; 74: 510-517.
15. Asplund J, Danielson M, Öhman P. Patients compliance in hypertension: The importance of the number of tablets. Br J Clin Pharmacol 1984; 17: 547-552.
16. Patel BV, Leslie RS, Thiebaud P, Nichol MB, Tang SSK, Solomon H, et al. Adherence with single-pill amlodipine/atorvastatin vs twopill regimen. Vasc Health Risk Manag 2008; 4: 673-681.
17. Gelman A, Hill J. Missing-data imputation. In: Gelman A, Hill J, editors. Data analysis using regression and multilevel/hierarchical models, Final Version. Cambridge: Cambridge University Press, 2006; 529-543.
18. Kansui Y, Ohtsubo T, Goto K, Sakata S, Ichishima K, Fukuhara M, et al. Association of serum uric acid with blood pressure in Japanese men: Cross-sectional study in work-site group. Circ J 2011; 75: 2827-2832.
19. Ohta Y, Matsumura K, Tsuchihashi T, Ohtsubo T, Arima H, Miwa Y, et al. Improvement of blood pressure control in a hypertension clinic in Japan: A 15-year follow-up study. Clin Exp Hypertens 2009; 31: 553-559.
20. Chobanian AV. Impact of nonadherence to antihypertensive therapy. Circulation 2009; 120: 1558-1560.
21. Murai K, Obara T, Ohkubo T, Metoki H, Oikawa T, Inoue R, et al. Current usage of diuretics among hypertensive patients in Japan: The Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2006; 29: 857-863.
22. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19: 1190-1196.
23. Burnier M, Brown RE, Ong SH, Keskinaslan A, Khan ZM. Issues in blood pressure control and the potential role of single-pill combination therapies. Int J Clin Pract 2009; 63: 790-798.
24. Schweizer J, Hilsmann U, Neumann G, Handrock R, Klebs S. Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination. Curr Med Res Opin 2007; 23: 2877-2885.
25. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 31-37.
26. van Onzenoort HAW, Menger FE, Neef C, Verberk WJ, Kroon AA, de Leeuw PW, et al. Participation in a clinical trial enhances adherence and persistence to treatment: A retrospective cohort study. Hypertension 2011; 58: 573-578.
27. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-1117.